Black Rock Inc. Beam Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,634,379 shares of BEAM stock, worth $140 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,634,379
Previous 6,705,626
13.85%
Holding current value
$140 Million
Previous $222 Million
19.26%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding BEAM
# of Institutions
247Shares Held
94.7MCall Options Held
425KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA9.93MShares$182 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.87MShares$162 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$162 Million1.24% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$86.5 Million0.05% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$83.1 Million72.77% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.29B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...